Go Pro

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 08/13/2026

KNB vs. TLY, UDG, UPR, SPI, and MGP

Should you buy Kanabo Group stock or one of its competitors? Kanabo Group's main competitors and comparable companies include Totally (TLY), UDG Healthcare (UDG), Uniphar (UPR), Spire Healthcare Group (SPI), and Medica Group (MGP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Kanabo Group compare to Totally?

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Totally has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, indicating that its stock price is 204% more volatile than the broader market.

In the previous week, Totally had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 0.75 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the media.

Company Overall Sentiment
Totally Positive
Kanabo Group Neutral

51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by company insiders. Comparatively, 24.3% of Kanabo Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Totally has a net margin of -2.94% compared to Kanabo Group's net margin of -892.40%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.94% -8.85% -2.42%
Kanabo Group -892.40%-80.03%-20.89%

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.00-£3.79M-£1.93N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Summary

Totally beats Kanabo Group on 9 of the 13 factors compared between the two stocks.

How does Kanabo Group compare to UDG Healthcare?

Kanabo Group (LON:KNB) and UDG Healthcare (LON:UDG) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

UDG Healthcare has a net margin of 0.00% compared to Kanabo Group's net margin of -892.40%. UDG Healthcare's return on equity of 0.00% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
UDG Healthcare N/A N/A N/A

3.8% of Kanabo Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled UDG Healthcare'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
UDG Healthcare Neutral

UDG Healthcare has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than UDG Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
UDG Healthcare£1.25B0.00N/A£25.40N/A

Summary

UDG Healthcare beats Kanabo Group on 6 of the 8 factors compared between the two stocks.

How does Kanabo Group compare to Uniphar?

Uniphar (LON:UPR) and Kanabo Group (LON:KNB) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

In the previous week, Uniphar's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Uniphar Neutral
Kanabo Group Neutral

Uniphar has a beta of 1.102, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market.

Uniphar has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uniphar£3.07B0.30£51.04M£19.5018.51
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

36.9% of Uniphar shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 7.9% of Uniphar shares are owned by insiders. Comparatively, 24.3% of Kanabo Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Uniphar has a net margin of 1.66% compared to Kanabo Group's net margin of -892.40%. Uniphar's return on equity of 13.14% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Uniphar1.66% 13.14% 3.76%
Kanabo Group -892.40%-80.03%-20.89%

Uniphar currently has a consensus target price of GBX 480, indicating a potential upside of 32.96%. Given Uniphar's stronger consensus rating and higher probable upside, equities research analysts plainly believe Uniphar is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Uniphar
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Uniphar beats Kanabo Group on 11 of the 14 factors compared between the two stocks.

How does Kanabo Group compare to Spire Healthcare Group?

Kanabo Group (LON:KNB) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Spire Healthcare Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Spire Healthcare Group£1.58B0.59£28.15M£4.0058.63

In the previous week, Spire Healthcare Group had 2 more articles in the media than Kanabo Group. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 equaled Spire Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Spire Healthcare Group Neutral

Spire Healthcare Group has a consensus price target of GBX 245, suggesting a potential upside of 4.48%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts clearly believe Spire Healthcare Group is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 21.8% of Spire Healthcare Group shares are owned by institutional investors. 24.3% of Kanabo Group shares are owned by company insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Spire Healthcare Group has a net margin of 1.04% compared to Kanabo Group's net margin of -892.40%. Spire Healthcare Group's return on equity of 2.22% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Spire Healthcare Group 1.04%2.22%3.73%

Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.933, suggesting that its stock price is 7% less volatile than the broader market.

Summary

Spire Healthcare Group beats Kanabo Group on 13 of the 15 factors compared between the two stocks.

How does Kanabo Group compare to Medica Group?

Kanabo Group (LON:KNB) and Medica Group (LON:MGP) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market. Comparatively, Medica Group has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Medica Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Medica Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Medica Group£76.98M0.00£7.20M£0.06N/A

Medica Group has a net margin of 9.35% compared to Kanabo Group's net margin of -892.40%. Medica Group's return on equity of 12.42% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Medica Group 9.35%12.42%6.62%

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled Medica Group'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Medica Group Neutral

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 88.4% of Medica Group shares are owned by institutional investors. 24.3% of Kanabo Group shares are owned by insiders. Comparatively, 2.9% of Medica Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Medica Group beats Kanabo Group on 8 of the 10 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupHealthcare Providers & Services IndustryHealthcare SectorLON Exchange
Market Cap£1.42M£9.76B£7.00B£2.88B
Dividend YieldN/A2.55%2.57%6.10%
P/E Ratio-0.1634.73271.41368.46
Price / Sales1.254.81607.3683,426.45
Price / Cash1.8224.8128.8727.89
Price / Book0.245.2411.097.08
Net Income-£8.18M£311.06M£3.45B£5.89B
7 Day PerformanceN/A-0.20%0.74%0.54%
1 Month PerformanceN/A-0.40%2.15%3.02%
1 Year PerformanceN/A18.66%63.00%64.50%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat
N/AN/A£1.42M£1.14MN/A20
TLY
Totally
N/AGBX 0.25
+4.2%
N/A+0.0%£491K£133.05MN/A1,668
UDG
UDG Healthcare
N/AN/AN/AN/A£2.72B£1.25B42.489,000
UPR
Uniphar
N/AGBX 364.30
-0.2%
GBX 480
+31.8%
+6.3%£945.63M£3.07B18.683,000
SPI
Spire Healthcare Group
0.6067 of 5 stars
GBX 230
-1.3%
GBX 245
+6.5%
+5.4%£921.38M£1.58B57.50420

Related Companies and Tools


This page (LON:KNB) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners